Annual report pursuant to Section 13 and 15(d)

INVENTORY

v3.22.1
INVENTORY
12 Months Ended
Dec. 31, 2021
INVENTORY  
INVENTORY

NOTE 3. INVENTORY

The Company’s inventory consists of the following:

    

December 31, 

December 31, 

($in thousands)

    

2021

    

2020

Raw materials

$

5,572

$

Work-in-process

 

 

Finished goods

 

4,290

 

1,404

Total inventories

$

9,862

$

1,404

The acquired Qbrexza inventory includes a fair value step-up of $6.5 million, which was fully expensed within cost of sales during the year ended December 31, 2021, as the inventory was sold to customers. For additional information on the Company’s asset acquisition of Qbrexza, please refer to Note 4.